N⁴-Octodecyl-1-β-D-arabinofuranosylcytosine (NOAC), a new anticancer drug: pharmacokinetics and metabolism in mice, distribution in human blood, uptake and cytotoxicity in lymphoma cells
Closed access
Date
1998Type
- Doctoral Thesis
ETH Bibliography
yes
Altmetrics
Permanent link
https://doi.org/10.3929/ethz-a-001992765Publication status
publishedExternal links
Search print copy at ETH Library
Publisher
ETH ZürichSubject
KREBSHEMMENDE ARZNEIMITTEL (PHARMAZIE); PHARMAKOKINETIK; ARZNEIMITTELMETABOLISMUS UND BIOTRANSFORMATION (PHARMAKOLOGIE); TIERVERSUCHE ZUR ARZNEIMITTELWIRKUNG UND -ANALYSE; CYTOTOXIZITÄT + CYTOTOXIKOLOGIE; LYMPHOME (PATHOLOGIE); CARCINOSTATICS + ANTINEOPLASTICS + ONCOSTATICS + CANCER REMEDIES (PHARMACY); PHARMACOKINETICS; DRUG METABOLISM AND BIOTRANSFORMATION (PHARMACOLOGY); ANIMAL EXPERIMENTS FOR DRUG ACTION AND DRUG ANALYSIS; CYTOTOXICOLOGY + CYTOTOXICITY; LYMPHOMATA (PATHOLOGY)Organisational unit
03325 - Folkers, Gerd (emeritus)
Notes
Diss. Naturwiss. ETH Zürich, Nr. 12908, 1998. Ref.: G. Folkers ; Korref.: R. A. Schwendener.More
Show all metadata
ETH Bibliography
yes
Altmetrics